Differential gene expression signatures between colorectal cancers with and without KRAS mutations: Crosstalk between the KRAS pathway and other signalling pathways-Reference-Cited by-同舟云学术

Differential gene expression signatures between colorectal cancers with and without KRAS mutations: Crosstalk between the KRAS pathway and other signalling pathways

Published:2011-09 Issue:13 Volume:47 Page:1946-1954
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Watanabe Toshiaki,Kobunai Takashi,Yamamoto Yoko,Matsuda Keiji,Ishihara Soichiro,Nozawa Keijiro,Iinuma Hisae,Ikeuchi Hiroki,Eshima Kiyoshi

Funder

Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan

the Ministry of Health, Labour and Welfare of Japan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant;Molinari;Br J Cancer,2009

2. EGFR antagonists in cancer treatment;Ciardiello;N Engl J Med,2008

3. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab;Khambata-Ford;J Clin Oncol,2007

4. KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience;Van Cutsem;J Clin Oncol,2008

5. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J Clin Oncol,2008

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of KRAS Mutation and Gene Pathways in Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study and Potential Implications for Therapy;International Journal of Molecular Sciences;2024-07-25

2. PITX1 plays essential functions in cancer;Frontiers in Oncology;2023-09-29

3. Tumor microenvironmental nutrients, cellular responses, and cancer;Cell Chemical Biology;2023-09

4. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications;MedComm;2023-05-02

5. PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability;Oncogenesis;2023-04-12